Signadori Bio
Paris · Founded 2025
About Signadori Bio
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.
Company Facts
- Founded: 2025
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $13.0M
- Funding stage: Seed
- Last round: Series Unknown (Mar 2025)
- Website: signadoribio.com
Social Profiles
Canonical: https://fsome.com/organization/signadori-bio-8258671 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.